BridgeMD
Tests treatment safety and results for Androgenic Alopecia
Official title A Clinical Study to Evaluate the Efficacy and Safety of Ultra in Promoting Hair Regrowth
ClinicalTrials.gov ID: NCT07588243
What this study is testing
- What it's testing
- The goal of this clinical study is to evaluate the efficacy and safety of the Ultra device for the treatment of hair regrowth by assessing the improvement of hair density and hair shaft diameter.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 22 to 70
You may be able to join if
- 22 - 70 years old
- Is willing to undergo study device use.
- Fitzpatrick skin type I-VI
- Clinical diagnosis of androgenetic alopecia (Norwood-Hamilton II-V or Ludwig I-II)
- Willing to avoid significant changes to hair (such as drastic haircuts and dying hair) during their involvement in the study.
You likely can't join if
- Is female and pregnant, has been pregnant within the last 3 months, is currently breast feeding, or planning a pregnancy during the study period.
- Has a diagnosis of other forms of alopecia (e.g., scarring alopecia, alopecia areata)
- Has recent use (within 6 months) of a systemic hair growth medications (e.g., oral finasteride).
- Inconsistent use of vitamins that can affect hair growth - must have stabilized use for at least 6 months prior to first treatment.
- Had previous treatment (such as laser or topical) to scalp within 6 months.
- Has a malignant disease, cancer, or uncontrolled medical condition.
See the full eligibility criteria
- 22 - 70 years old
- Is willing to undergo study device use.
- Fitzpatrick skin type I-VI
- Clinical diagnosis of androgenetic alopecia (Norwood-Hamilton II-V or Ludwig I-II)
- Willing to avoid significant changes to hair (such as drastic haircuts and dying hair) during their involvement in the study.
- Willing to maintain current diet and exercise routine throughout study duration.
- Understands and accepts the study condition to not receive any other procedures to the treatment area or to undergo any procedures, take any medications, supplements, or partake in any other treatments indicated for...
- Understands and accepts the study condition of and agrees that he or she is able to be present for all study visits.
- Willing to comply with all requirements of the study and is able to provide written informed consent.
- Is female and pregnant, has been pregnant within the last 3 months, is currently breast feeding, or planning a pregnancy during the study period.
- Has a diagnosis of other forms of alopecia (e.g., scarring alopecia, alopecia areata)
- Has recent use (within 6 months) of a systemic hair growth medications (e.g., oral finasteride).
- Inconsistent use of vitamins that can affect hair growth - must have stabilized use for at least 6 months prior to first treatment.
- Had previous treatment (such as laser or topical) to scalp within 6 months.
- Has a malignant disease, cancer, or uncontrolled medical condition.
- Has an impaired immune system due to immunosuppressive diseases, such as AIDS and HIV, or use of immunosuppressive medications
The study team makes the final eligibility decision.
Where it's taking place
- Glenview, Illinois, United States
- Westford, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 22 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Glenview, Illinois, United States; Westford, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.